title: [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
abstract: Interleukin-1 (IL-1) is one of the main inflammatory mediators associated with development of rheumatoid arthritis (RA). Deficiency in secretion of the natural IL-1 antagonist was found in RA patients, and enhanced joint inflammation. This finding was confirmed by numerous studies using the animal model of the disease. Two randomized, multicenter clinical trials with anakinra, a recombinant IL-1 receptor antagonist (rHHHuIL-1Ra), revealed that application of anakinra with or without methotrexate induces remission (ACR 20) in 38-71% of patients with RA. Induction of remission was dose and treatment-time-dependent. The present paper reviews theoretical application of rHuIL-1Ra in patients with RA and summarizes results of published clinical trials of the drug.
authors.affiliation: Katedra i Klinika Chorób Wewnetrznych i Reumatologii Sl. AM 40-029 Katowice, ul. Ziołowa 45/47.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Zoń-Giebel
authors.forename: Anna
authors.initials: A
authors.lastname: Kotulska
authors.forename: Sebastian
authors.initials: S
authors.lastname: Giebel
authors.forename: Sham A
authors.initials: SA
authors.lastname: Cader
authors.forename: Eugeniusz Józef
authors.initials: EJ
authors.lastname: Kucharz
mesh_terms: D018501:Antirheumatic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D008727:Methotrexate / Q000494:pharmacology* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D012795:Sialoglycoproteins / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1; D012795:Sialoglycoproteins; D008727:Methotrexate
vernacular_title: Antagonista receptora interleukiny-1 w leczeniu reumatoidalnego zapalenia stawów.